AGF Investments Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $40.7M | Sell |
572,858
-18,870
| -3% | -$1.37M | 0.39% | 85 |
|
|
2022
Q2 | $45.6M | Sell |
591,728
-19,798
| -3% | -$1.51M | 0.41% | 86 |
|
|
2022
Q1 | $44.7M | Sell |
611,526
-73,719
| -11% | -$4.95M | 0.33% | 95 |
|
|
2021
Q4 | $42.7M | Sell |
685,245
-29,829
| -4% | -$1.75M | 0.31% | 103 |
|
|
2021
Q3 | $42.3M | Sell |
715,074
-235,881
| -25% | -$15.5M | 0.32% | 107 |
|
|
2021
Q2 | $63.5M | Sell |
950,955
-45,426
| -5% | -$2.96M | 0.48% | 79 |
|
|
2021
Q1 | $62.9M | Sell |
996,381
-86,599
| -8% | -$5.39M | 0.5% | 78 |
|
|
2020
Q4 | $67.2M | Sell |
1,082,980
-109,957
| -9% | -$6.76M | 0.57% | 61 |
|
|
2020
Q3 | $71.9M | Buy |
1,192,937
+393
| +0% | +$23.7K | 0.72% | 41 |
|
|
2020
Q2 | $70.1M | Sell |
1,192,544
-28,051
| -2% | -$1.68M | 0.74% | 36 |
|
|
2020
Q1 | $68M | Buy |
1,220,595
+35,115
| +3% | +$2.15M | 0.82% | 33 |
|
|
2019
Q4 | $76.1M | Sell |
1,185,480
-29,804
| -2% | -$1.71M | 0.91% | 29 |
|
|
2019
Q3 | $61.6M | Sell |
1,215,284
-30,015
| -2% | -$1.41M | 0.77% | 41 |
|
|
2019
Q2 | $56.5M | Sell |
1,245,299
-41,286
| -3% | -$1.92M | 0.68% | 57 |
|
|
2019
Q1 | $61.4M | Sell |
1,286,585
-12,064
| -0.9% | -$601K | 0.69% | 51 |
|
|
2018
Q4 | $67.5M | Buy |
1,298,649
+7,204
| +0.6% | +$387K | 0.81% | 36 |
|
|
2018
Q3 | $80.2M | Sell |
1,291,445
-7,113
| -0.5% | -$422K | 0.81% | 42 |
|
|
2018
Q2 | $71.9M | Buy |
1,298,558
+118,814
| +10% | +$6.42M | 0.74% | 44 |
|
|
2018
Q1 | $74.6M | Buy |
1,179,744
+20,487
| +2% | +$1.32M | 0.81% | 30 |
|
|
2017
Q4 | $71M | Sell |
1,159,257
-18,968
| -2% | -$1.19M | 0.69% | 46 |
|
|
2017
Q3 | $75.1M | Buy |
1,178,225
+64,687
| +6% | +$3.78M | 0.82% | 32 |
|
|
2017
Q2 | $62.1M | Buy |
1,113,538
+18,415
| +2% | +$1M | 0.71% | 51 |
|
|
2017
Q1 | $59.5M | Sell |
1,095,123
-283
| -0% | -$15.5K | 0.65% | 54 |
|
|
2016
Q4 | $64M | Sell |
1,095,406
-8,133
| -0.7% | -$445K | 0.74% | 46 |
|
|
2016
Q3 | $59.5M | Sell |
1,103,539
-8,392
| -0.8% | -$539K | 0.67% | 54 |
|
|
2016
Q2 | $81.8M | Buy |
1,111,931
+118,192
| +12% | +$8.35M | 0.91% | 25 |
|
|
2016
Q1 | $63.4M | Buy |
993,739
+62,367
| +7% | +$3.93M | 0.77% | 39 |
|
|
2015
Q4 | $64.1M | Buy |
931,372
+49,388
| +6% | +$3.26M | 0.79% | 38 |
|
|
2015
Q3 | $52.5M | Buy |
881,984
+53,759
| +6% | +$3.41M | 0.66% | 52 |
|
|
2015
Q2 | $55M | Buy |
828,225
+96,344
| +13% | +$6.35M | 0.59% | 58 |
|
|
2015
Q1 | $47.2M | Buy |
731,881
+34,098
| +5% | +$2.13M | 0.51% | 71 |
|
|
2014
Q4 | $41.2M | Buy |
697,783
+20,601
| +3% | +$1.16M | 0.44% | 87 |
|
|
2014
Q3 | $34.7M | Buy |
677,182
+6,245
| +0.9% | +$312K | 0.36% | 104 |
|
|
2014
Q2 | $32.6M | Buy |
670,937
+41,094
| +7% | +$2.03M | 0.32% | 113 |
|
|
2014
Q1 | $32.7M | Buy |
629,843
+36,748
| +6% | +$1.96M | 0.33% | 109 |
|
|
2013
Q4 | $31.5M | Buy |
593,095
+20,348
| +4% | +$1.04M | 0.32% | 100 |
|
|
2013
Q3 | $26.5M | Sell |
572,747
-79,800
| -12% | -$3.5M | 0.3% | 111 |
|
|
2013
Q2 | $29.2M | Buy |
+652,547
| New | +$28.3M | 0.34% | 104 |
|
Other funds holding BMY
AGF Investments Inc's BMY Position: Q3 2022 in Review
AGF Investments Inc reduced its Bristol-Myers Squibb (BMY) stake by 3.2% in Q3 2022, selling an estimated $1.37M and leaving 572,858 shares worth $40.7M. The position accounts for 0.39% of the portfolio, ranked #85.
AGF Investments Inc first reported a position in BMY in Q2 2013 and has held it in 38 quarters since. The position peaked at $81.8M in Q2 2016. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- AGF Investments Inc held 572,858 shares of Bristol-Myers Squibb worth $40.7M as of Q3 2022.
- AGF Investments Inc sold 18,870 Bristol-Myers Squibb shares in Q3 2022, an estimated $1.37M.
- Bristol-Myers Squibb made up 0.39% of AGF Investments Inc's portfolio in Q3 2022, its #85 holding.
- AGF Investments Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 38 quarters since.
- AGF Investments Inc's Bristol-Myers Squibb position peaked at $81.8M in Q2 2016.
- 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on AGF Investments Inc's 13F filing for Q3 2022, filed 10 Nov 2022.